Vaccines and Public Health | Johns Hopkins | Bloomberg School of Public Health

illustration of microscopic view of marburg virus

What We Know About Rwanda’s Marburg Virus Outbreak

October 16, 2024

How Rwanda is working to contain its first-ever outbreak of the deadly virus—including by testing a new vaccine.

Infectious Diseases

International Health

Vaccines

Bloomberg School

Mother holding child on her lap while she receives vaccine

10 Reasons To Vaccinate Your 5 & Under Child for COVID-19 as Soon as Possible

June 17, 2022

It’s finally their turn: The FDA authorizes COVID-19 vaccines for the youngest age bracket.

COVID-19

Vaccines

Bloomberg School

Graphic with a family and covid virus floating around with hand holding vaccine vial

The Long Road to COVID-19 Vaccines for Kids Under 5

June 13, 2022

Experts agree on the benefits of vaccinating kids. So, why did it take so long to authorize COVID shots for the youngest age group?

COVID-19

Vaccines

Child and Adolescent Health

Bloomberg School

What You Need to Know About the Novavax Protein-Based Vaccine

June 10, 2022

The FDA has authorized Novavax, a protein-based vaccine, for emergency use. Here’s what you need to know.

COVID-19

Technology and Innovation

Vaccines

Bloomberg School

Aerial view of thousands of people forming shape of an injector

What VAERS Is (And Isn’t)

May 03, 2022

Anyone can report a post-vaccination health issue to the Vaccine Adverse Event Reporting System—which anti-vaccination activists often misuse to sow misinformation and distrust.

COVID-19

Data

Vaccines

Bloomberg School

A path of scrabble tiles with arrows leads to decision which changes the path in two directions on colorful background.

A Quick Guide for Talking With Vaccine-Hesitant Parents

April 19, 2022

Encouraging parents to vaccinate their kids against Covid-19 can be a delicate dance. Data, rhetoric, and insults won’t help. Listening and empathy can.

COVID-19

Vaccines

Child and Adolescent Health

Public Health Magazine

Vaccines Faculty Experts

Looking for prominent public health experts in the field of vaccines? They’re here at the Bloomberg School of Public Health.

William John Moss

Professor

Epidemiology

Anna P. Durbin

Professor

International Health

Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.

Daniel Salmon

Professor

International Health

Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making.

Ruth Karron

Professor

International Health

Vaccines

Vaccines Headlines

What We Know About Rwanda’s Marburg Virus Outbreak

10 Reasons To Vaccinate Your 5 & Under Child for COVID-19 as Soon as Possible

The Long Road to COVID-19 Vaccines for Kids Under 5

What You Need to Know About the Novavax Protein-Based Vaccine

What VAERS Is (And Isn’t)

A Quick Guide for Talking With Vaccine-Hesitant Parents

Vaccines Faculty Experts

William John Moss

Anna P. Durbin

Daniel Salmon

Ruth Karron

Departments

Programs

Centers & Institutes

Upcoming Events